Publications by authors named "Jan-Gerard Maring"

Claim this Profile
S
Safety, Feasibility, and Patient Experience of Ten-Minute Pembrolizumab Infusions: A Prospective Cohort Study.
Elianne C S de Boer, Helle-Brit Fiebrich-Westra, Gijs M M Lenis, Peter M J Plomp, Mireille A Edens, Jan Gerard Maring

JCO Oncol Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Dihydropyrimidine Dehydrogenase Enzyme-Guided Dosing of 5-Fluorouracil: Prioritizing Precision Over Dose Reduction.
Helle-Brit Fiebrich-Westra, Christina Haroun, Remco van der Galiën, Daphne den Besten-Bertholee, Maarten J Deenen, Jan Gerard Maring

JCO Precis Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Beyond Infusion: Real-World Insights Into Infusion-Related Reactions in Monoclonal Antibody Therapy.
Elise J Smolders, Elianne C S de Boer, Helle-Brit Fiebrich-Westra, Remco van der Galiën, Peter M J Plomp, Jan Gerard Maring

JCO Oncol Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Infusion: Real-World Insights Into Infusion-Related Reactions in Monoclonal Antibody Therapy.
Elise J Smolders, Elianne C S de Boer, Helle-Brit Fiebrich-Westra, Remco van der Galiën, Peter M J Plomp, Jan Gerard Maring

JCO Oncol Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus-based development and practice testing of a generic quality indicator set for parenteral medication administration at home: a RAND appropriateness method study.
Jedidja Lok-Visser, Roald Hunneman, Cecile H J Bekkers, P Margreet G Filius, Anke Lenferink, Jan Gerard Maring

BMJ Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Treatment of Patients With GI Cancer Using Pre-emptive Genotyping/Phenotyping Plus Pharmacokinetic-Guided Dosing of 5-Fluorouracil.
Helle-Brit Fiebrich-Westra, Christina Haroun, Remco van der Galiën, Daphne den Besten-Bertholee, Maarten J Deenen, Jan Gerard Maring

JCO Precis Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Real-World Data for Machine-Learning Algorithms to Predict the Treatment Response in Advanced Melanoma: A Pilot Study for Personalizing Cancer Care.
Richard M Brohet, Elianne C S de Boer, Joram M Mossink, Joni J N van der Eerden, Alexander Oostmeyer, Jan Gerard Maring

JCO Clin Cancer Inform· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymine as potential biomarker to predict 5-FU systemic exposure in patients with gastro-intestinal cancer: a prospective pharmacokinetic study (FUUT-trial).
Maarten A Hanrath, Evi Banken, Sebastian A H van den Wildenberg, Daan van de Kerkhof, Dirk Jan A R Moes, Jan Gerard Maring

Cancer Chemother Pharmacol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of telemonitoring on correct drug use, complications and quality of life among patients with multiple myeloma (ITUMM): A study protocol for an open-label, parallel-group, randomized controlled trial.
Job F H Eijsink, Paul A F Geerts, Karin Kamminga, Mireille A Edens, Cornelis Boersma, Jan Gerard Maring

PLoS One· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lethal Capecitabine Toxicity in Patients With Complete Dihydropyrimidine Dehydrogenase Deficiency Due to Ultra-Rare Variants.
André B P van Kuilenburg, Marjolein C H Pleunis-van Empel, Rick B Brouwer, Angelique E J Sijben, Daan G Knapen, Jan Gerard Maring

JCO Precis Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Patient-Reported Outcomes in Clinical Trials in Metastatic Colorectal Cancer: A Scoping Review.
Jan Gerard Maring, Job F H Eijsink, Friso D Tichelaar, Pawida Veluwenkamp-Worawutputtapong, Maarten J Postma

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-national comparison of medication use in Australian and Dutch nursing homes.
Katja Taxis, Sjoerd Kochen, Hans Wouters, Froukje Boersma, Maring Jan Gerard

Age Ageing· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.
Daphne Bertholee, Jan Gerard Maring, André B P van Kuilenburg

Clin Pharmacokinet· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-national comparison of medication use in Australian and Dutch nursing homes.
Katja Taxis, Sjoerd Kochen, Hans Wouters, Froukje Boersma, Jan Gerard Maring

Age Ageing· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an oral uracil loading test to identify DPD-deficient patients using a limited sampling strategy.
Maurice C van Staveren, Andre B P van Kuilenburg, Henk-Jan Guchelaar, Judith Meijer, Cornelis J A Punt, Jan Gerard Maring

Br J Clin Pharmacol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients.
Maurice C van Staveren, Frans Opdam, Henk-Jan Guchelaar, André B P van Kuilenburg, Jan Gerard Maring

Cancer Chemother Pharmacol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuing inappropriate medication in nursing home residents (DIM-NHR Study): protocol of a cluster randomised controlled trial.
Hans Wouters, Elise H Quik, Froukje Boersma, Peder Nygård, Judith Bosman, Jan-Gerard Maring

BMJ Open· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patients.
André Bp van Kuilenburg, Jan Gerard Maring

Pharmacogenomics· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 5-fluorouracil pharmacokinetics in cancer patients with a c.1905+1G>A mutation in DPYD by means of a Bayesian limited sampling strategy.
André B P van Kuilenburg, Peter Häusler, Andreas Schalhorn, Michael W T Tanck, Johannes H Proost, Jan Gerard Maring

Clin Pharmacokinet· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency.
Maurice C van Staveren, Barbara Theeuwes-Oonk, Henk Jan Guchelaar, André B P van Kuilenburg, Jan Gerard Maring

Cancer Chemother Pharmacol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity.
André B P van Kuilenburg, Judith Meijer, Adri N P M Mul, Rutger Meinsma, Veronika Schmid, Jan Gerard Maring

Hum Genet· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism.
Jan Gerard Maring, Floris M Wachters, Monique Slijfer, J Marina Maurer, H Marike Boezen

Eur J Clin Pharmacol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine and epirubicin plasma concentration-related excretion in saliva in patients with non-small cell lung cancer.
Jan Gerard Maring, Floris M Wachters, Marina Maurer, Donald R A Uges, Elisabeth G E de Vries

Ther Drug Monit· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple and sensitive fully validated HPLC-UV method for the determination of 5-fluorouracil and its metabolite 5,6-dihydrofluorouracil in plasma.
Jan Gerard Maring, Leonie Schouten, Ben Greijdanus, Elisabeth G E de Vries, Donald R A Uges

Ther Drug Monit· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of epirubicin and its metabolite epirubicinol in saliva and plasma by HPLC.
Wilma I W Dodde, Jan Gerard Maring, Gert Hendriks, Floris M Wachters, Harry J M Groen

Ther Drug Monit· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis